Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Schizophrenia Research

• Publication date

  2011-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2011.06.030PMID 21798716PMCID PMC3196271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

  2011influential reference
• Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

  2011cited by this paper
• Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies.

  2010cited by this paper
• Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

  2010cited by this paper
• Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).

  2010influential reference
• CNTRICS final task selection: social cognitive and affective neuroscience-based measures.

  2009cited by this paper
• Emotional response deficits in schizophrenia: insights from affective science.

  2008cited by this paper
• Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities.

  2008cited by this paper
• The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond.

  2008cited by this paper
• Consistency of Brief Psychiatric Rating Scale Factor Structure across a Broad Spectrum of Schizophrenia Patients

  2007cited by this paper
• Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia.

  2007cited by this paper
• Negative , depressive and cognitive symptoms of schizophrenia . Nice , March 2004

  2006cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006influential reference
• Anhedonia in schizophrenia: a review of assessment strategies.

  2006cited by this paper
• Dysfunction of ventral striatal reward prediction in schizophrenia

  2006cited by this paper
• The structure of negative symptoms within schizophrenia: implications for assessment.

  2006cited by this paper
• Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.

  2006cited by this paper
• The factorial structure of the schedule for the deficit syndrome in schizophrenia.

  2006cited by this paper
• Commentary: consensus statement on negative symptoms.

  2006cited by this paper
• Presidential Paper Doing it all Bass-Ackwards: The development of hierarchical factor structures from the top down

  2006cited by this paper
• Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

  1999cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.

  1996influential reference
• A depression rating scale for schizophrenics.

  1990influential reference
• The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations

  1989cited by this paper
• Cluster Analysis

  1984cited by this paper
• Estimation of latent ability using a response pattern of graded scores

  1968cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Asociality in schizophrenia: A review of historical foundations, measures, mechanisms, and treatments.

  2026cites this paper
• Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia

  2025cites this paper
• Negative symptoms, cognition, and community functioning in early psychosis.

  2025cites this paper
• Moderation Effect of Emotional Expressivity on the Associations Between Schizotypal Traits, Autistic Traits and Social Pleasure

  2025cites this paper
• COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS)

  2025cites this paper
• Efficacy of high-frequency transcranial magnetic stimulation to improve negative symptoms in patients with Schizophrenia: A meta-analysis of randomized controlled trials.

  2025cites this paper
• Blunted Ventral Striatal Reactivity to Social Reward Is Associated with More Severe Motivation and Pleasure Deficits in Psychosis.

  2025cites this paper
• Exploratory analysis of the relationship between striatal connectivity and apathy during phosphodiesterase 10 inhibition in schizophrenia: findings from a randomized crossover trial

  2025cites this paper
• Common Neural Deficits in Social and Monetary Reinforcement Learning in Schizophrenia.

  2025cites this paper
• The role of trauma, attachment, and voice-hearer’s appraisals: a latent profile analysis in the AVATAR2 trial

  2025cites this paper
• Relationships between cognition and symptoms across mood and psychotic disorders.

  2025cites this paper
• Cerebellar-Prefrontal Connectivity Predicts Negative Symptom Severity Across the Psychosis Spectrum

  2025cites this paper
• Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial

  2025cites this paper
• Disorganized Striatal Functional Connectivity as a Partially Shared Pathophysiological Mechanism in Both Schizophrenia and Major Depressive Disorder: A Transdiagnostic fMRI Study

  2025cites this paper
• Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping

  2025cites this paper
• Targeting Positive Affect as a Way to Improve Social Anhedonia in Schizophrenia.

  2025cites this paper
• Anhedonia Across and Beyond the Schizophrenia Spectrum

  2024influential citation
• Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties.

  2024cites this paper
• An ERP Study of Face Processing in Schizophrenia, Bipolar Disorder, and Socially Isolated Individuals from the Community

  2024cites this paper
• Peak alpha frequency in schizophrenia, bipolar disorder, and healthy volunteers: Associations with visual information processing and cognition.

  2024cites this paper
• Defeatist performance beliefs in individuals with recent-onset schizophrenia: Relationships with cognition and negative symptoms.

  2024cites this paper
• An Introduction to the Human Connectome Project for Early Psychosis.

  2024cites this paper
• A transdiagnostic approach of negative symptoms in psychiatric disorders: replication of a two-factor structure in major depressive disorder and bipolar disorder

  2024cites this paper
• Motivation and Pleasure Deficits Undermine the Benefits of Social Affiliation in Psychosis

  2024cites this paper
• Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.

  2024cites this paper
• The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression

  2024cites this paper
• Understanding the Mechanisms of Cognitive Remediation on Recovery in People With Early Psychosis: A Mediation and Moderation Analysis

  2024cites this paper
• Psychotic Arousal and the Psychopathology of Acute Schizophrenia: An Exploratory Study of the Experiential Emotional State in Acute Psychosis

  2024cites this paper
• Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms

  2024cites this paper
• Decoding Early Psychoses: Unraveling Stable Microstructural Features Associated with Psychopathology Across Independent Cohorts.

  2024cites this paper
• Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).

  2024influential citation
• “Goals in Focus”—a targeted CBT approach for motivational negative symptoms of psychosis: study protocol for a randomized-controlled feasibility trial

  2023cites this paper
• External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning

  2023cites this paper
• The longitudinal structure of negative symptoms in treatment resistant schizophrenia.

  2023cites this paper
• Dissociation of Cognitive Effort-Based Decision Making and its Associations with Symptoms, Cognition, and Everyday Life Function Across Schizophrenia, Bipolar Disorder, and Depression.

  2023cites this paper
• Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes.

  2023cites this paper
• Enhanced Punishment Responses in Patients With Schizophrenia: An Event-Related Potential Study

  2023cites this paper
• Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia

  2023cites this paper
• Increasing social and community participation in veterans living with schizophrenia: A treatment outcome study.

  2023cites this paper
• Associations between theory of mind and clinical symptoms in recent onset schizophrenia spectrum disorders

  2023cites this paper
• Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning

  2023cites this paper
• The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties

  2023cites this paper
• Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties.

  2023cites this paper
• Differential deficits in social versus monetary reinforcement learning in schizophrenia: Associations with facial emotion recognition.

  2023cites this paper
• A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT.

  2023cites this paper
• Psychometric properties of the Fatigue Catastrophizing Scale in a general population and its clinical utility in schizophrenia and breast cancer patients

  2023cites this paper
• Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study.

  2023cites this paper
• Evaluation of a new intrinsic and extrinsic motivation scale in youth with psychosis spectrum symptoms

  2023cites this paper
• Negative and depressive symptoms differentially relate to real-world anticipatory and consummatory pleasure in schizophrenia.

  2022cites this paper
• Cortical and Subcortical Structural Morphometric Profiles in Individuals with Nonaffective and Affective Early Illness Psychosis.

  2022cites this paper
• Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia

  2022cites this paper
• Primary and Secondary Negative Symptoms in Schizophrenia

  2022cites this paper
• Aberrant reward processing to positive versus negative outcomes across psychotic disorders.

  2022cites this paper
• Revisiting the latent structure of negative symptoms in schizophrenia: Evidence from two second-generation clinical assessments.

  2022cites this paper
• Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia

  2022cites this paper
• N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A preliminary MRS study.

  2022cites this paper
• Cluster analysis of negative symptoms identifies distinct negative symptom subgroups.

  2022cites this paper
• Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study.

  2022cites this paper
• Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia

  2022influential citation
• Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses

  2022cites this paper
• Validation of accelerometry as a digital phenotyping measure of negative symptoms in schizophrenia

  2022cites this paper
• Clinical symptoms and social functioning in schizophrenia.

  2022cites this paper
• Recognizing Psychosis in Autism Spectrum Disorder

  2022cites this paper
• Theories and models of negative symptoms in schizophrenia and clinical implications

  2022cites this paper
• Relationship between White Matter Alterations and Pathophysiological Symptoms in Patients with Ultra-High Risk of Psychosis, First-Episode, and Chronic Schizophrenia

  2022cites this paper
• Correlates of real-world goal-directed behavior in schizophrenia

  2021cites this paper
• A comparison of stages of attention for social and nonsocial stimuli in schizophrenia: An ERP study.

  2021cites this paper
• Factor structure and internal consistency of the Clinical Assessment Interview for Negative Symptoms (CAINS) on a sample of persons with psychotic disorders in Bosnia and Herzegovina

  2021influential citation
• The Effects of Anhedonia in Social Context

  2021cites this paper
• Mechanisms Underlying Motivational Dysfunction in Schizophrenia

  2021cites this paper
• Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome

  2021cites this paper
• Validity and reliability of the Vigour Assessment Scale in avolitional schizophrenia outpatients.

  2021cites this paper
• The Many Faces of Negative Symptoms in Schizophrenia

  2021cites this paper
• Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments.

  2021cites this paper
• Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale.

  2021cites this paper
• A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS)

  2021cites this paper
• Alpha Event-related Desynchronization During Reward Processing in Schizophrenia

  2021cites this paper
• mHealth for Illness Self-Management for People With Schizophrenia

  2021cites this paper
• EPA guidance on assessment of negative symptoms in schizophrenia

  2021cites this paper
• Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development

  2021cites this paper
• Self-stigma in psychotic disorders: Clinical, cognitive, and functional correlates in a diverse sample.

  2021cites this paper
• What gets in the way of social engagement in schizophrenia?

  2021cites this paper
• Enhancing stress reactivity and wellbeing in early schizophrenia: A randomized controlled trial of Integrated Coping Awareness Therapy (I-CAT).

  2021cites this paper
• Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis

  2021cites this paper
• Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention.

  2020cites this paper
• Negative Symptoms and Their Assessment in Schizophrenia and Related Disorders

  2020cites this paper
• Personality Traits and Disorders in Adolescents at Clinical High Risk for Psychosis: Toward a Clinically Meaningful Diagnosis

  2020cites this paper
• The influence of negative and affective symptoms on anhedonia self-report in schizophrenia.

  2020cites this paper
• 長期入院統合失調症者の社会機能に陰性症状が与える影響:～失快楽症，非社会性，意欲の低下，感情鈍麻，言語の貧困と社会機能との関連～

  2020cites this paper
• Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS)

  2020cites this paper
• Update kognitive Verhaltenstherapie bei Psychosen

  2020cites this paper
• Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits

  2020cites this paper
• Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-analysis

  2020cites this paper
• Orbitofrontal-striatal structural alterations linked to negative symptoms at different stages of the schizophrenia spectrum

  2020cites this paper
• Association between negative symptom domains and happiness in schizophrenia.

  2020cites this paper
• A cognitive model of diminished expression in schizophrenia: The interface of metacognition, cognitive symptoms and language disturbances.

  2020cites this paper
• Using machine learning of computerized vocal expression to measure blunted vocal affect and alogia

  2020cites this paper
• Retinal functioning and reward processing in schizophrenia.

  2020cites this paper
• Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

  2020cites this paper
• Factorial Structure of the Serbian Version of the Clinical Assessment Interview for Negative Symptoms – Evidence for Three Factors of Negative Symptoms

  2020cites this paper